36139384|t|Melatonin Attenuates Spinal Cord Injury in Mice by Activating the Nrf2/ARE Signaling Pathway to Inhibit the NLRP3 Inflammasome.
36139384|a|BACKGROUND: Spinal cord injury (SCI) is a central nervous system (CNS) trauma involving inflammation and oxidative stress, which play important roles in this trauma's pathogenesis. Therefore, controlling inflammation is an effective strategy for SCI treatment. As a hormone, melatonin is capable of producing antioxidation and anti-inflammation effects. In the meantime, it also causes a neuroprotective effect in various neurological diseases. Nrf2/ARE/NLRP3 is a well-known pathway in anti-inflammation and antioxidation, and Nrf2 can be positively regulated by melatonin. However, how melatonin regulates inflammation during SCI is poorly explored. Therefore, it was investigated in this study whether melatonin can inhibit the NLRP3 inflammasome through the Nrf2/ARE signaling pathway in a mouse SCI model. METHODS: A model of SCI was established in C57BL/6 mice and PC12 cells. The motor function of mice was detected by performing an open field test, and Nissl staining and terminal deoxynucleotidyl transferase dUTP nick end labeling were carried out to evaluate the survival of neurons. Mitochondrial dysfunction was detected by transmission electron microscopy (TEM) and by assessing the mitochondrial membrane potential. In addition, the expression of NLRP3 inflammasome and oxidative-stress-related proteins were detected through Western blot and immunofluorescence double staining. RESULTS: By inhibiting neuroinflammation and reducing neuronal death, melatonin promotes the recovery of neuromotor function. Besides this, melatonin is able to reduce the damage that causes neuronal mitochondrial dysfunction, reduce the level of reactive oxygen species (ROS) and malondialdehyde, and enhance the activity of superoxide dismutase and the production of glutathione peroxidase. Mechanically, melatonin inhibits the activation of NLRP3 inflammasomes and reduces the secretion of pro-inflammatory factors through the Nrf2/ARE signaling. CONCLUSIONS: In conclusion, melatonin inhibits the NLRP3 inflammasome through stimulation of the Nrf2/ARE pathway, thereby suppressing neuroinflammation, reducing mitochondrial dysfunction, and improving the recovery of nerve function after SCI.
36139384	0	9	Melatonin	Chemical	MESH:D008550
36139384	21	39	Spinal Cord Injury	Disease	MESH:D013119
36139384	43	47	Mice	Species	10090
36139384	66	70	Nrf2	Gene	18024
36139384	108	113	NLRP3	Gene	216799
36139384	140	158	Spinal cord injury	Disease	MESH:D013119
36139384	160	163	SCI	Disease	MESH:D013119
36139384	170	205	central nervous system (CNS) trauma	Disease	MESH:D020196
36139384	216	228	inflammation	Disease	MESH:D007249
36139384	286	292	trauma	Disease	MESH:D014947
36139384	332	344	inflammation	Disease	MESH:D007249
36139384	374	377	SCI	Disease	MESH:D013119
36139384	403	412	melatonin	Chemical	MESH:D008550
36139384	460	472	inflammation	Disease	MESH:D007249
36139384	550	571	neurological diseases	Disease	MESH:D020271
36139384	573	577	Nrf2	Gene	18024
36139384	582	587	NLRP3	Gene	216799
36139384	620	632	inflammation	Disease	MESH:D007249
36139384	656	660	Nrf2	Gene	18024
36139384	692	701	melatonin	Chemical	MESH:D008550
36139384	716	725	melatonin	Chemical	MESH:D008550
36139384	736	748	inflammation	Disease	MESH:D007249
36139384	756	759	SCI	Disease	MESH:D013119
36139384	833	842	melatonin	Chemical	MESH:D008550
36139384	859	864	NLRP3	Gene	216799
36139384	890	894	Nrf2	Gene	18024
36139384	922	927	mouse	Species	10090
36139384	928	931	SCI	Disease	MESH:D013119
36139384	959	962	SCI	Disease	MESH:D013119
36139384	982	989	C57BL/6	CellLine	CVCL:C0MU
36139384	990	994	mice	Species	10090
36139384	999	1003	PC12	CellLine	CVCL:0481
36139384	1033	1037	mice	Species	10090
36139384	1108	1145	terminal deoxynucleotidyl transferase	Gene	21673
36139384	1146	1150	dUTP	Chemical	MESH:C027078
36139384	1223	1248	Mitochondrial dysfunction	Disease	MESH:D028361
36139384	1390	1395	NLRP3	Gene	216799
36139384	1545	1562	neuroinflammation	Disease	MESH:D000090862
36139384	1576	1590	neuronal death	Disease	MESH:D009410
36139384	1592	1601	melatonin	Chemical	MESH:D008550
36139384	1662	1671	melatonin	Chemical	MESH:D008550
36139384	1722	1747	mitochondrial dysfunction	Disease	MESH:D028361
36139384	1769	1792	reactive oxygen species	Chemical	MESH:D017382
36139384	1794	1797	ROS	Chemical	MESH:D017382
36139384	1803	1818	malondialdehyde	Chemical	MESH:D008315
36139384	1929	1938	melatonin	Chemical	MESH:D008550
36139384	1966	1971	NLRP3	Gene	216799
36139384	2019	2031	inflammatory	Disease	MESH:D007249
36139384	2052	2056	Nrf2	Gene	18024
36139384	2100	2109	melatonin	Chemical	MESH:D008550
36139384	2123	2128	NLRP3	Gene	216799
36139384	2169	2173	Nrf2	Gene	18024
36139384	2207	2224	neuroinflammation	Disease	MESH:D000090862
36139384	2235	2260	mitochondrial dysfunction	Disease	MESH:D028361
36139384	2313	2316	SCI	Disease	MESH:D013119
36139384	Association	MESH:D000090862	216799
36139384	Negative_Correlation	MESH:D008550	MESH:D013119
36139384	Association	MESH:D028361	18024
36139384	Negative_Correlation	MESH:D008550	MESH:D017382
36139384	Association	MESH:D007249	216799
36139384	Negative_Correlation	MESH:D008550	MESH:D009410
36139384	Association	MESH:D007249	18024
36139384	Negative_Correlation	18024	216799
36139384	Positive_Correlation	MESH:D008550	18024
36139384	Negative_Correlation	MESH:D008315	MESH:D008550
36139384	Negative_Correlation	MESH:D008550	MESH:D007249
36139384	Association	MESH:D000090862	18024
36139384	Association	MESH:D013119	18024
36139384	Negative_Correlation	MESH:D008550	MESH:D020271
36139384	Negative_Correlation	MESH:D008550	216799
36139384	Negative_Correlation	MESH:D008550	MESH:D028361
36139384	Association	MESH:D013119	216799
36139384	Negative_Correlation	MESH:D008550	MESH:D000090862

